Cargando…

Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS

Detalles Bibliográficos
Autores principales: Novi, Giovanni, Ivaldi, Federico, Sbragia, Elvira, Mikulska, Malgorzata, Pesce, Giampaola, Inglese, Matilde, Kerlero de Rosbo, Nicole, Uccelli, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051194/
https://www.ncbi.nlm.nih.gov/pubmed/32098867
http://dx.doi.org/10.1212/NXI.0000000000000695
_version_ 1783502727646543872
author Novi, Giovanni
Ivaldi, Federico
Sbragia, Elvira
Mikulska, Malgorzata
Pesce, Giampaola
Inglese, Matilde
Kerlero de Rosbo, Nicole
Uccelli, Antonio
author_facet Novi, Giovanni
Ivaldi, Federico
Sbragia, Elvira
Mikulska, Malgorzata
Pesce, Giampaola
Inglese, Matilde
Kerlero de Rosbo, Nicole
Uccelli, Antonio
author_sort Novi, Giovanni
collection PubMed
description
format Online
Article
Text
id pubmed-7051194
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-70511942020-03-13 Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS Novi, Giovanni Ivaldi, Federico Sbragia, Elvira Mikulska, Malgorzata Pesce, Giampaola Inglese, Matilde Kerlero de Rosbo, Nicole Uccelli, Antonio Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2020-02-25 /pmc/articles/PMC7051194/ /pubmed/32098867 http://dx.doi.org/10.1212/NXI.0000000000000695 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Clinical/Scientific Notes
Novi, Giovanni
Ivaldi, Federico
Sbragia, Elvira
Mikulska, Malgorzata
Pesce, Giampaola
Inglese, Matilde
Kerlero de Rosbo, Nicole
Uccelli, Antonio
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
title Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
title_full Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
title_fullStr Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
title_full_unstemmed Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
title_short Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS
title_sort ocrelizumab does not impair b- and t-cell responses to primary vzv infection in a patient with ms
topic Clinical/Scientific Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7051194/
https://www.ncbi.nlm.nih.gov/pubmed/32098867
http://dx.doi.org/10.1212/NXI.0000000000000695
work_keys_str_mv AT novigiovanni ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms
AT ivaldifederico ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms
AT sbragiaelvira ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms
AT mikulskamalgorzata ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms
AT pescegiampaola ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms
AT inglesematilde ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms
AT kerleroderosbonicole ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms
AT uccelliantonio ocrelizumabdoesnotimpairbandtcellresponsestoprimaryvzvinfectioninapatientwithms